|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000119138 |
Summary for KLF9 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000119138 | Gene symbol | KLF9 |
| Gene name | Kruppel like factor 9 | |
| HGNC | 1123 | |
| Entrez ID | 687 | |
| Gene type | protein_coding | |
| Synonyms | KLF9| | |
| UniProtAcc | Q13886 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for KLF9 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KLF9 | 2.09e+03 | -1.45e+00 | 1.84e-01 | -7.89e+00 | 3.12e-15 | 3.69e-14 | HNSC |
| KLF9 | 3.73e+03 | -1.44e+00 | 1.56e-01 | -9.24e+00 | 2.39e-20 | 5.23e-19 | KIRP |
| KLF9 | 6.86e+03 | -1.02e+00 | 2.23e-01 | -4.57e+00 | 4.85e-06 | 2.14e-05 | KICH |
| KLF9 | 4.58e+03 | -2.18e+00 | 3.90e-01 | -5.60e+00 | 2.18e-08 | 1.03e-06 | ESCA |
| KLF9 | 4.74e+03 | -2.51e+00 | 4.29e-01 | -5.85e+00 | 5.03e-09 | 6.11e-08 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KLF9 | 5.08e+03 | -1.27e+00 | 2.63e-01 | -4.83e+00 | 1.38e-06 | 6.74e-06 | LIHC |
| KLF9 | 3.56e+03 | -1.73e+00 | 8.15e-02 | -2.12e+01 | 8.88e-100 | 3.46e-98 | BRCA |
| KLF9 | 9.27e+02 | -2.43e+00 | 3.69e-01 | -6.58e+00 | 4.76e-11 | 1.42e-09 | READ |
Top |
Sex-biased somatic mutation for KLF9 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for KLF9 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for KLF9 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for KLF9 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for KLF9 |
| TFs related to KLF9. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BLCA | PRDM6 | KLF9 | 4.14e+00 | 4.69e-04 | 5.81e+00 | 9.98e-01 | Female-biased |
| BLCA | ZNF181 | KLF9 | 3.89e+00 | 3.51e-03 | 5.00e+00 | 9.93e-01 | Female-biased |
| BLCA | ZNF182 | KLF9 | 4.32e+00 | 1.17e-03 | 5.73e+00 | 9.98e-01 | Female-biased |
| BLCA | ZNF418 | KLF9 | 5.33e+00 | 3.57e-04 | 7.07e+00 | 9.99e-01 | Female-biased |
| CHOL | PRDM6 | KLF9 | 5.15e+00 | 1.19e-02 | 6.04e+00 | 9.87e-01 | Female-biased |
| CHOL | ZNF182 | KLF9 | 4.98e+00 | 9.71e-03 | 5.93e+00 | 9.89e-01 | Female-biased |
| CHOL | ZNF418 | KLF9 | 6.11e+00 | 5.75e-04 | 7.74e+00 | 9.99e-01 | Female-biased |
| DLBC | PRDM6 | KLF9 | 6.56e+00 | 9.91e-01 | 5.66e+00 | 8.89e-03 | Male-biased |
| DLBC | ZNF182 | KLF9 | 6.52e+00 | 9.91e-01 | 5.61e+00 | 8.42e-03 | Male-biased |
| DLBC | ZNF418 | KLF9 | 7.45e+00 | 9.85e-01 | 6.69e+00 | 1.46e-02 | Male-biased |
| LAML | ZNF418 | KLF9 | 6.05e+00 | 1.84e-02 | 6.79e+00 | 9.81e-01 | Female-biased |
| LGG | PRDM6 | KLF9 | 5.72e+00 | 9.81e-01 | 5.34e+00 | 1.74e-02 | Male-biased |
| LGG | ZNF182 | KLF9 | 5.60e+00 | 9.83e-01 | 5.20e+00 | 1.52e-02 | Male-biased |
| READ | PRDM6 | KLF9 | 3.53e+00 | 1.90e-03 | 4.80e+00 | 9.94e-01 | Female-biased |
| READ | ZNF182 | KLF9 | 3.71e+00 | 3.43e-03 | 4.82e+00 | 9.92e-01 | Female-biased |
| READ | ZNF418 | KLF9 | 4.55e+00 | 7.57e-04 | 6.11e+00 | 9.99e-01 | Female-biased |
| SARC | NFATC1 | KLF9 | 8.56e+00 | 9.84e-01 | 8.08e+00 | 1.62e-02 | Male-biased |
| SARC | PRDM6 | KLF9 | 6.01e+00 | 9.81e-01 | 5.54e+00 | 1.79e-02 | Male-biased |
| SARC | ZFP28 | KLF9 | 6.55e+00 | 9.84e-01 | 6.05e+00 | 1.58e-02 | Male-biased |
| SARC | ZNF124 | KLF9 | 6.90e+00 | 9.91e-01 | 6.33e+00 | 9.10e-03 | Male-biased |
| SARC | ZNF182 | KLF9 | 5.99e+00 | 9.81e-01 | 5.52e+00 | 1.82e-02 | Male-biased |
| SARC | ZNF418 | KLF9 | 7.63e+00 | 1.00e+00 | 6.37e+00 | 2.16e-04 | Male-biased |
| KLF9 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for KLF9 |
| RBPs related to ES in KLF9. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KLF9 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000119138 | LINC02172,hsa-mir-216b,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | MAGI2-AS3,hsa-mir-216b,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | LINC01140,hsa-mir-216b,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AL162171.3,hsa-mir-216b,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AC009506.1,hsa-mir-431,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | NNT-AS1,hsa-mir-431,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AC093010.2,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AC104836.1,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AC012085.2,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | AC087854.1,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | NNT-AS1,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | LINC02202,hsa-mir-93,KLF9 | Male-specific ceRNA | TCGA-HNSC |
| ENSG00000119138 | LINC01806,hsa-mir-330,KLF9 | Female-specific ceRNA | TCGA-LIHC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs234796 | chr9:78611923:T:A | - | -0.162794135191367 | 1.15539586561475e-06 | LUAD | Female-baised eQTL |
| rs201209364 | chr9:78818411:G:A | - | 0.0558418177415008 | 0.0184039899978559 | LUAD | Female-baised eQTL |
| rs7858944 | chr9:74330033:C:T | - | -0.0557078508451391 | 0.035245610862455 | LUAD | Female-baised eQTL |
| rs11142922 | chr9:68559394:G:A | - | 0.0543578325473963 | 0.0439963255133686 | LUAD | Female-baised eQTL |
| rs7871229 | chr9:74326396:G:T | - | -0.0539665093088727 | 0.0450517053046143 | LUAD | Female-baised eQTL |
| rs4745315 | chr9:74327581:G:C | - | -0.0539665093088727 | 0.0450517053046143 | LUAD | Female-baised eQTL |
| rs4237265 | chr9:74329086:T:C | - | -0.0503663197004146 | 0.0465258675971068 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs76044749 | chr9:74458933:G:A | - | 0.184852663021753 | 0.00368574871593774 | SARC | Male-baised eQTL |
| rs1352809 | chr9:73972436:T:C | - | -0.104237063786424 | 0.0172950086837361 | LIHC | Male-baised eQTL |
| rs7867440 | chr9:73986921:A:G | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs4745275 | chr9:73988610:C:T | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs10119997 | chr9:73989006:G:A | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs2087685 | chr9:73990512:G:T | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs4744702 | chr9:73991376:G:A | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs4744703 | chr9:73991556:G:A | - | -0.103426501920066 | 0.0191815384824587 | LIHC | Male-baised eQTL |
| rs7868047 | chr9:73987355:A:C | - | -0.102936809769225 | 0.0205988878070264 | LIHC | Male-baised eQTL |
| rs1491455 | chr9:73956944:A:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs1388361 | chr9:73958078:G:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs1602499 | chr9:73963359:T:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs11515738 | chr9:73964668:C:T | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs1602498 | chr9:73965560:C:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs4409462 | chr9:73969205:C:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7851517 | chr9:73969265:C:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7850926 | chr9:73969523:G:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10122195 | chr9:73969902:A:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10119065 | chr9:73970057:C:T | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7047222 | chr9:73970521:T:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10869303 | chr9:73971203:A:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7859775 | chr9:73971885:T:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7870812 | chr9:73971911:C:T | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs1352810 | chr9:73972328:A:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs6560362 | chr9:73974924:G:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10869304 | chr9:73978246:T:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs2087687 | chr9:73978946:G:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10869305 | chr9:73980523:T:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs1491457 | chr9:73981485:G:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10123345 | chr9:73981732:A:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7022065 | chr9:73982129:T:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7038240 | chr9:73983202:C:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs4570231 | chr9:73983948:C:G | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs962730 | chr9:73984175:C:A | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs7031807 | chr9:73985018:A:C | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs12350214 | chr9:73986169:C:T | - | -0.0996048104666991 | 0.028029556772188 | LIHC | Male-baised eQTL |
| rs10125265 | chr9:73980791:G:T | - | -0.0993606480488526 | 0.0289465931771135 | LIHC | Male-baised eQTL |
| rs7855349 | chr9:73977878:T:A | - | -0.097371639310491 | 0.032984247407257 | LIHC | Male-baised eQTL |
| rs11143746 | chr9:73986509:G:A | - | -0.097371639310491 | 0.032984247407257 | LIHC | Male-baised eQTL |
| rs7048420 | chr9:77008928:T:G | - | 0.0861855799015081 | 0.00611413533985113 | KIRC | Male-baised eQTL |
| rs7858555 | chr9:76996916:C:T | - | 0.093046460969412 | 0.00759618118050357 | KIRC | Male-baised eQTL |
| rs7847586 | chr9:76996959:T:C | - | 0.093046460969412 | 0.00759618118050357 | KIRC | Male-baised eQTL |
| rs7857755 | chr9:76996960:G:C | - | 0.093046460969412 | 0.00759618118050357 | KIRC | Male-baised eQTL |
| rs11145206 | chr9:77009003:T:G | - | 0.0861239480032628 | 0.00779655928061457 | KIRC | Male-baised eQTL |
| rs13295491 | chr9:76996384:G:A | - | 0.0922456748656646 | 0.00880034148332208 | KIRC | Male-baised eQTL |
| rs13300948 | chr9:76996577:C:T | - | 0.0922456748656646 | 0.00880034148332208 | KIRC | Male-baised eQTL |
| rs7863001 | chr9:76989372:A:C | - | 0.116184797191944 | 0.0137395939508735 | KIRC | Male-baised eQTL |
| rs7873970 | chr9:76997147:A:C | - | 0.0866019008038179 | 0.0157496730244154 | KIRC | Male-baised eQTL |
| rs35910498 | chr9:76997762:A:G | - | 0.0852358852030997 | 0.0193176273796774 | KIRC | Male-baised eQTL |
| rs34054475 | chr9:76997854:T:C | - | 0.0852358852030997 | 0.0193176273796774 | KIRC | Male-baised eQTL |
| rs34568160 | chr9:76997859:C:G | - | 0.0852358852030997 | 0.0193176273796774 | KIRC | Male-baised eQTL |
| rs7858152 | chr9:76997270:G:A | - | 0.0850157742788089 | 0.0200639927833304 | KIRC | Male-baised eQTL |
| rs11145195 | chr9:76997350:A:G | - | 0.0850157742788089 | 0.0200639927833304 | KIRC | Male-baised eQTL |
| rs11145196 | chr9:76997639:G:C | - | 0.0850157742788089 | 0.0200639927833304 | KIRC | Male-baised eQTL |
| rs7848890 | chr9:76998210:A:G | - | 0.0845196955459079 | 0.0203496559836214 | KIRC | Male-baised eQTL |
| rs7852070 | chr9:76998264:T:C | - | 0.0845196955459079 | 0.0203496559836214 | KIRC | Male-baised eQTL |
| rs7847718 | chr9:76997073:T:C | - | 0.084745327444055 | 0.0214394839980138 | KIRC | Male-baised eQTL |
| rs11790024 | chr9:76998368:A:T | - | 0.0844386395113535 | 0.0217652527831291 | KIRC | Male-baised eQTL |
| rs11792299 | chr9:76998813:G:A | - | 0.0840510139842041 | 0.0218063036969224 | KIRC | Male-baised eQTL |
| rs11788430 | chr9:76998750:C:T | - | 0.08389919370999 | 0.0224890502998585 | KIRC | Male-baised eQTL |
| rs11145197 | chr9:76999033:A:G | - | 0.0828893927112471 | 0.0273707127849545 | KIRC | Male-baised eQTL |
| rs13285896 | chr9:76996685:T:C | - | 0.0853358716360786 | 0.0274362982104499 | KIRC | Male-baised eQTL |
| rs13299948 | chr9:76996727:G:A | - | 0.0853358716360786 | 0.0274362982104499 | KIRC | Male-baised eQTL |
| rs35179088 | chr9:77008794:A:G | - | 0.104143427282098 | 0.0339870463749034 | KIRC | Male-baised eQTL |
| rs12378793 | chr9:76999019:G:C | - | 0.0818419862962835 | 0.0453067290393851 | KIRC | Male-baised eQTL |
| rs28759022 | chr9:76999514:G:A | - | 0.0818419862962835 | 0.0453067290393851 | KIRC | Male-baised eQTL |
| rs1609625 | chr9:70878050:A:G | - | 0.0708356675347375 | 0.0169233213989784 | BLCA | Male-baised eQTL |
| rs589737 | chr9:80258672:C:T | - | 0.0642626966753873 | 0.000959526110985369 | COAD | Male-baised eQTL |
| rs2185265 | chr9:69312409:A:G | - | -0.0594908610919913 | 0.00585152080004169 | COAD | Male-baised eQTL |
| rs1934736 | chr9:75870466:T:A | - | -0.0845171373307627 | 0.013141208026612 | COAD | Male-baised eQTL |
| rs10867672 | chr9:69498585:A:G | - | 0.0702787018912331 | 0.0137111115207938 | COAD | Male-baised eQTL |
| rs10867477 | chr9:69418729:T:C | - | 0.0723257346084611 | 0.0205264083511526 | COAD | Male-baised eQTL |
| rs1331972 | chr9:69420570:C:G | - | 0.0723257346084611 | 0.0205264083511526 | COAD | Male-baised eQTL |
| rs11138566 | chr9:69421453:C:T | - | 0.0723257346084611 | 0.0205264083511526 | COAD | Male-baised eQTL |
| rs932967 | chr9:69421464:A:G | - | 0.0719913757413456 | 0.0217654631963524 | COAD | Male-baised eQTL |
| rs72727239 | chr9:72209871:C:T | - | 0.0754098239117377 | 0.0247227965822522 | COAD | Male-baised eQTL |
| rs72727238 | chr9:72209794:A:G | - | 0.0747954044868037 | 0.0267006929430712 | COAD | Male-baised eQTL |
| rs4745456 | chr9:75867334:A:T | - | -0.0749688747763581 | 0.0300214763444122 | COAD | Male-baised eQTL |
| rs4745454 | chr9:75866603:T:G | - | -0.0746207549944367 | 0.0311952207812678 | COAD | Male-baised eQTL |
| rs2767017 | chr9:75876162:A:G | - | -0.0740822222323242 | 0.0312926813243837 | COAD | Male-baised eQTL |
| rs62561983 | chr9:72213310:C:A | - | 0.0722684327913412 | 0.0335937174396704 | COAD | Male-baised eQTL |
| rs4745581 | chr9:69074964:G:A | - | 0.048458301038075 | 0.0342013800251615 | COAD | Male-baised eQTL |
| rs478778 | chr9:71087684:G:A | - | 0.0497485469035632 | 0.0356294796204427 | COAD | Male-baised eQTL |
| rs6560561 | chr9:76893032:A:G | - | 0.0481501167002621 | 0.0438131012119368 | COAD | Male-baised eQTL |
| rs10867357 | chr9:69324515:A:G | - | -0.0526097954813414 | 0.0444422294441506 | COAD | Male-baised eQTL |
| rs6559468 | chr9:69324930:G:A | - | -0.0526097954813414 | 0.0444422294441506 | COAD | Male-baised eQTL |
| rs2589615 | chr9:72688737:C:T | - | 0.0440011972142949 | 0.0445305765796179 | COAD | Male-baised eQTL |
| rs7852930 | chr9:69331080:G:A | - | -0.0524672976861958 | 0.0451162892073882 | COAD | Male-baised eQTL |
| rs2094372 | chr9:75381543:T:G | - | -0.0554821147176022 | 0.0451537427547437 | COAD | Male-baised eQTL |
| rs10780297 | chr9:69320661:C:A | - | -0.0478885375581933 | 0.0452723946993015 | COAD | Male-baised eQTL |
| rs7862512 | chr9:76784780:C:T | - | 0.0826186655836237 | 0.0491133255992279 | COAD | Male-baised eQTL |
| rs12555818 | chr9:76892947:A:T | - | 0.076551798129366 | 0.049899018629806 | COAD | Male-baised eQTL |
| rs10867360 | chr9:69330198:G:C | - | -0.0517718181027865 | 0.0499068589494887 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of KLF9 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000119138 | KLF9 | C0005910 | Body Weight | 1 | CTD_human |
| ENSG00000119138 | KLF9 | C0014175 | Endometriosis | 1 | CTD_human |
| ENSG00000119138 | KLF9 | C0040128 | Thyroid Diseases | 1 | CTD_human |
| ENSG00000119138 | KLF9 | C0269102 | Endometrioma | 1 | CTD_human |
| ENSG00000119138 | KLF9 | C1135196 | Heart Failure, Diastolic | 1 | CTD_human |
